27 Dec Jack Springer Appointed as Executive Chairman
Capture Vascular announced today that Jack Springer has been appointed as Executive Chairman of the Board. Mr. Springer has extensive experience and a proven track record of success in the medical device space. Since 2011, Jack has consulted with many device companies and currently serves on the boards of Vatrix Medical and Aneurysm Diagnostic. Prior to starting his consulting practice, Jack was head of the U.S. business for Invatec when they were acquired by Medtronic, Inc. for $500M in April of 2010. Post-acquisition he led the integration of the U.S. business as the V.P. of Commercial Operations and Brand Marketing.
His career started out in sales and marketing at Abbott Laboratories where he won numerous awards for sales performance. He then moved to Cordis Corporation, a Division of Johnson and Johnson, where he initially took on sales training and development roles and subsequent sales management and marketing positions. He was promoted to Global General Manager in 2003 and served in that role until April of 2006. During his 12 year tenure at Cordis, the business unit grew at an annual rate of over 25% per year reaching sales of over $550M. Cordis Endovascular has been recognized as one of the most successful cardiovascular device companies during this period. He drove the development and introduction of several major products that changed how physicians treat peripheral vascular disease.
He also holds significant experience in developing businesses outside the U.S. in both Asia Pacific and Europe. Mr. Springer received his BA degree from McDaniel College in Westminster, Md. and has completed additional course work at the University of Michigan Business School. He also earned a commission in the U.S. Army and served four years on active duty before moving into healthcare.